Skip to main content
. 2023 Sep 19;21:641. doi: 10.1186/s12967-023-04320-2

Fig. 2.

Fig. 2

The tumor heterogeneity characteristic of 5 prostate cancer patients pre-and post- androgen deprivation therapy. A Distribution of the tumor mutation load; B Distribution of CNA load; C Distribution of wGII; D Distribution of SDI; E Distribution of the overall intra tumor heterogeneity estimated; F Distribution of the Mutant-allele tumor heterogeneity